Results of the Citalopram to Enhance Cognition in Huntington Disease Trial

OBJECTIVE: Evaluate citalopram for executive functioning in HD. DESIGN: Randomized, double-blind, placebo-controlled. PATIENTS: Thirty-three adults with HD, cognitive complaints and no depression (Hamilton Depression Rating Scale ≤12). INTERVENTION: Citalopram 20 mg or placebo [7 visits, 20 weeks],...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beglinger, Leigh J., Adams, William H., Langbehn, Douglas, Fiedorowicz, Jess G., Jorge, Ricardo, Biglan, Kevin, Caviness, John, Olson, Blair, Robinson, Robert G., Kieburtz, Karl, Paulsen, Jane S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3960314/
https://ncbi.nlm.nih.gov/pubmed/24375941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25750
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados